Physician
Hematology
Dr. Tanya L. Repka, MD
|
|
Give Review
Tanya Repka is an expert in the field of Hematology. He attended University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACP)". Tanya Repka is also published. He has 18 publications published. The lastest publication: "Peripheral blood versus bone marrow for hematopoietic cell transplantation.'
Publications
- Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescents.
- Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host Disease: a case report and review of the literature.
- Creating environment for Cancer care.
- Trastuzumab and interleukin-2 in HER2-positive metastatic breast Cancer: a pilot study.
- IL-2-based immunotherapy after autologous transplantation for lymphoma and breast Cancer induces immune activation and cytokine release: a phase I/II trial.
- Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem Cell transplantation: a prospective random...
- Nonrandom association of free iron with membranes of sickle and beta-thalassemic erythrocytes.
- Effect of excess alpha-hemoglobin chains on Cellular and membrane oxidation in model beta-thalassemic erythrocytes.
- Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood Cells both in vitro and in vivo.
- Reticulocytosis: defective reticulin degradation, a case report.
- Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents.
- Detection, characterization, and bioavailability of membrane-associated iron in the intact sickle red Cell.
- Evaluation of warfarin initiation regimens in elderly inpatients.
- Nonmyeloablative HPC transplantation.
- Enhancement of the anti-tumor activity of a peripheral blood progenitor Cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in pat...
- Natural killer cell cytotoxicity of breast Cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.
- Peripheral blood versus bone marrow for hematopoietic Cell transplantation.
Schools
University of Mn Med Sch
Fairview University Med Center
Hennepin Co Med Center
Pacific Presby Med Center
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Preferred Plus POS
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CHAMPVA
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- National Elevator
- Choice Plus POS
- Navigate POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
Education
-
University of Minnesota at Fairview -
Hennepin County Medical Center -
University of Minnesota Medical School
Hospital
-
Regions Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Pritesh V. Lohar, MD |
|
Dr. Basem S. Goueli, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel A. Nikcevich, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jay D. Baker, DO |
|
Dr. Steven A. Kuross, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. James E. Krook, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Brad J. Davis, MD |
|
|
Dr. Benjamin R. Koch, MD
This Doctor is OpenDoctor Recommended.
|